clock menu more-arrow no yes mobile

Filed under:

Morning Magic: Your daily headlines

A collection of Orlando Magic content from around the web

If you buy something from an SB Nation link, Vox Media may earn a commission. See our ethics statement.

Toronto Raptors play the Orlando Magic Steve Russell/Toronto Star via Getty Images

We gather all Magic content from around the web and deliver it to you. Consider it one-stop shopping for all Magic headlines. But first...

Magic Tweets of the Day

Magic Headlines

Nikola Vucevic and Aaron Gordon both underwent MRIs to determine the extent of their ankle sprains, and it could be a while before we se Vooch back on the court, writes our Zach Oliver.

With the offense struggling and injuries mounting, should the Magic make a trade? Our Garrett Townsend offers his suggestions.

Nikola Vucevic will be reevaluated in 7 to 10 days, writes Roy Parry of the Orlando Sentinel.

The Magic need to have “that fighting mentality” to make up for the loss of Nikola Vucevic and Aaron Gordon, writes Josh Robbins of The Athletic.

The Magic now must find a way to overcome injuries to Nikola Vucevic and Aaron Gordon, writes John Denton of

After suffering major losses to injury, several players on the Magic must now step up, writes Omar Cabrera of Orlando Magic Daily.

Three ways Jonathan Isaac has improved, courtesy of Joe Chambers of Orlando Magic Daily.

Three reasons the Magic shouldn’t trade for DeMar DeRozan, courtesy of Luke Duffy of Hoops Habit.

Markelle Fultz is a decent NBA player, and that’s a huge relief, writes Matt Ellentuck of SB Nation.

Markelle Fultz is thriving with the Magic, writes James D. Tillman III of Hoops Habit.

A brief Player Journal video that goes behind the scenes with Aaron Gordon, courtesy of Yahoo Sports.

ICYMI, remember back in the day when the Magic faced the extremely shorthanded Pacers the night after the “Malice at the Palace”? Our Mike Ferguson looks back.

Penny Hardaway and Memphis Basketball are paying the price for challenging the NCAA in the James Wiseman case, writes Mark Giannotto of The Commercial Appeal.